FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/11/005190 [Registered on: 10/11/2014] Trial Registered Retrospectively
Last Modified On: 06/11/2014
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to compare two different ways of giving fentanyl drug– continuous infusion or intermittent doses for pain relief in newborn babies 
Scientific Title of Study   Comparison of continuous infusion versus intermittent bolus doses of fentanyl for analgesia in neonates– An open label randomized controlled trial 
Trial Acronym  FANCI trial 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Abiramalatha T 
Designation  Senior PG Registrar (DM Neonatology) 
Affiliation  Christian Medical College, Vellore 
Address  Department of Neonatology, ISSCC Building, Christian Medical College, Vellore

Vellore
TAMIL NADU
632004
India 
Phone  04163073311  
Fax  0416-2232035  
Email  abi_paeds@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DrKurien Anil Kuruvilla 
Designation  Professor 
Affiliation  Christian Medical College, Vellore 
Address  Department of Neonatology, ISSCC Building, Christian Medical College, Vellore

Vellore
TAMIL NADU
632004
India 
Phone  04163073311  
Fax  0416-2232035  
Email  anilkk@cmcvellore.ac.in  
 
Details of Contact Person
Public Query
 
Name  Abiramalatha T 
Designation  Senior PG Registrar (DM Neonatology) 
Affiliation  Christian Medical College, Vellore 
Address  Department of Neonatology, ISSCC Building, Christian Medical College, Vellore

Vellore
TAMIL NADU
632004
India 
Phone  04163073311  
Fax  0416-2232035  
Email  abi_paeds@yahoo.com  
 
Source of Monetary or Material Support  
Department fund, Department of Neonatology, Christian Medical College, Vellore 
Institutional Review Board, Christian Medical College, Vellore 
 
Primary Sponsor  
Name  Institutional Review Board 
Address  Christian Medical College Vellore 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Abiramalatha T  Level 3 nursery  Department of Neonatology ISSCC Building Christian Medical College Vellore
Vellore
TAMIL NADU 
04163073311

abi_paeds@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Christian Medical College,Vellore  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Analgesia and Sedation for neonates on mechanical ventilation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Continuous infusion of fentanyl  Continuous infusion of fentanyl 1 microgram/kg/hour for 48 hours (minimum 24 hours) 
Intervention  Intermittent doses of fentanyl   Intermittent doses of fentanyl 1 microgram/kg/dose once every 4 hours for 48 hours (minimum 24 hours) 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  Newborn babies who are likely to require mechanical ventilation for 48 hours (minimum 24 hours) 
 
ExclusionCriteria 
Details  1.Major congenital anomalies/ chromosomal disorders 2.Hypoxic Ischemic encephalopathy (HIE) stage 2 or 3 3.Postoperative babies
4.Refusal of consent 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the exposure as concentrations of Fentanyl achieved in the serum between the two groups  Continuous Infusion - Fentanyl serum concentrations at: 0, 2, 8, 24 hours on DAY 1. 36 and 48 hours on DAY 2.
Intermittent dosage Group - Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6–DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2 
 
Secondary Outcome  
Outcome  TimePoints 
To measure the exposure as Cmax (peak concentration) and area under concentration time curve (AUC 0-24 hours or AUC 0-48 hours) in babies receiving continuous infusion of fentanyl  Fentanyl serum concentrations at 0, 2, 8, 24 hours on DAY 1 and 36, 48 hours on DAY 2 
To measure the exposure as Cmax (when measured) at each bolus and AUC, through the 24 hour (or 48 hour) period, using limited time points, in babies receiving intermittent bolus doses of fentanyl  Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6 on DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2 
To find the inter-individual variability in serum concentrations of fentanyl in the two groups, especially the effect of gestational age on fentanyl clearance  Day 1 and 2 of fentanyl 
To compare the analgesic efficacy between continuous infusion and intermittent bolus doses of fentanyl using pain scores  Day 1 and 2 of fentanyl 
To compare the side effects of fentanyl between the two groups  Day 1 and 2 of fentanyl 
 
Target Sample Size   Total Sample Size="98"
Sample Size from India="98" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/11/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   The trial will be published in an indexed journal 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
Background
    Fentanyl is commonly used for analgesia in newborn infants. The drug has a rapid clearance in adults. But hepatic metabolism is immature at birth, thus the half- life is prolonged in neonates. So, intermittent doses of fentanyl may be as good as continuous infusion in maintaining serum concentrations and hence the analgesic efficacy in neonates. 
Aim
    To compare continuous infusion and intermittent doses of fentanyl for analgesia in neonates using serum concentrations, pain scores and side-effects
Methods
    In the present study, newborn babies who are likely to need mechanical ventilation and hence analgesia and sedation for preferably 48 hours (minimum of 24 hours) will be recruited into the study after informed written consent. The babies will be stratified into 2 categories of <32 weeks or ≥32 weeks gestational age. In both groups, babies will be administered a loading dose of fentanyl (1 microgram/kg/dose) at the time of intubation, or at the time of starting ventilator care if the baby has already been intubated in the labour room or casualty. 
   Babies will be randomized into two groups: continuous infusion of fentanyl (Group 1) or intermittent doses once in every 4 hours (Group 2). The babies in the continuous group and intermittent group will be compared based on: 1) serum fentanyl concentrations 2) clinical efficacy 3) adverse effects. 
   Serum concentrations of fentanyl will be estimated as follows: 
Group 1 - Continuous infusion - samples (0.5 ml) will be collected
a. Prior to starting continuous infusion(0 hour) and at 2,8 and 24 hours from start of infusion
b. At 36 and 48 hours - 2 samples on Day 2
Group 2 - Intermittent doses–
a. Peak (Cmax) and trough concentrations of the 1st dose (at 0 and 4 hours)
b. Peak and trough concentrations of the 6th dose (at 20 and 24 hours) on day 1
c. On Day 2 , peak and trough of the 12th dose or the last dose, whichever is later
    Pain assessment will be done clinically using standard neonatal pain scoring systems, viz. N-PASS to assess ongoing pain, and NIPS to assess acute pain during heel prick, intravenous cannulation or other procedures. 
   Adverse effects of fentanyl will also be assessed in both groups
1. Decreased gastrointestinal motility will be assessed daily based on not passing meconium, and gastric retention defined by the volume of nasogastric aspirate/vomiting in 24 hours. 
2. Urinary retention (loss of spontaneous urination with enlarged bladder/ need for catheterization) will be evaluated daily. 
3. Incidence of hypotension (Blood pressure < 10th percentile for the gestational age and postnatal age) 
4. Chest wall rigidity (clinically defined as no chest rise despite patent airway and adequate pressures with either mechanical or manual ventilation).

 
Close